abstract |
Disclosed are halogen substituted imidazo[1,5-a][1,2,4]triazolo[1,5--d][1,4]benzodiazepine derivatives of formula (I), and their pharmaceutically acceptable acid addition salts. The compounds may be used for the treatment of cognitive disorders, anxiety, Alzheimer's disease and schizophrenia. |